Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells

Bone

Volumn 44, Issue 5, 2009, Pages 830-839

  Brounais, Bénédicte ^a,b   David, Emmanuelle ^a,b   Chipoy, Céline ^a,b   Trichet, Valérie ^a,b   Ferré, Virginie ^b,c   Charrier, Céline ^a,b   Duplomb, Laurence ^a,b,c   Berreur, Martine ^a,b   Rédini, Françoise ^a,b   Heymann, Dominique ^a,b,c   Blanchard, Frédéric ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c HÔTEL DIEU   (France)

Author keywords

Lentivirus; Oncostatin M; Osteoblast; Osteocyte; Osteosarcoma

Indexed keywords

ONCOSTATIN M; SCLEROSTIN; STAUROSPORINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALVARIA; CELL DIFFERENTIATION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; LENTIVIRINAE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; OSTEOSARCOMA; RAT; VIRAL GENE DELIVERY SYSTEM;

EID: 63649125253     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.12.021     Document Type: Article

References (37)

1. Tanaka M., and Miyajima A. Oncostatin M, a multifunctional cytokine. Rev. Physiol. Biochem. Pharmacol. 149 (2003) 39-52
2. Auguste P., Guillet C., Fourcin M., Olivier C., Veziers J., Pouplard-Barthelaix A., et al. Signaling of type II oncostatin M receptor. J. Biol. Chem. 272 (1997) 15760-15764
3. Chen S.H., and Benveniste E.N. Oncostatin M: a pleiotropic cytokine in the central nervous system. Cytokine Growth Factor Rev. 15 (2004) 379-391
4. Baumann H., Wang Y., Richards C.D., Jones C.A., Black T.A., and Gross K.W. Endotoxin-induced renal inflammatory response. Oncostatin M as a major mediator of suppressed renin expression. J. Biol. Chem. 275 (2000) 22014-22019
5. Kamiya A., Kinoshita T., Ito Y., Matsui T., Morikawa Y., Senba E., et al. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J. 18 (1999) 2127-2136
6. Langdon C., Kerr C., Hassen M., Hara T., Arsenault A.L., and Richards C.D. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am. J. Pathol. 157 (2000) 1187-1196
7. Horn D., Fitzpatrick W.C., Gompper P.T., Ochs V., Bolton-Hansen M., Zarling J., et al. Regulation of cell growth by recombinant oncostatin M. Growth Factors 2 (1990) 157-165
8. Grant S.L., and Begley C.G. The oncostatin M signalling pathway: reversing the neoplastic phenotype?. Mol. Med. Today 5 (1999) 406-412
9. Klausen P., Pedersen L., Jurlander J., and Baumann H. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene 19 (2000) 3675-3683
10. Halfter H., Lotfi R., Westermann R., Young P., Ringelstein E.B., and Stogbauer F.T. Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM). Growth Factors 15 (1998) 135-147
11. Bellido T., Borba V.Z., Roberson P., and Manolagas S.C. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology 138 (1997) 3666-3676
12. Chipoy C., Brounais B., Trichet V., Battaglia S., Berreur M., Oliver L., et al. Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53. Oncogene 26 (2007) 6653-6664
13. Chipoy C., Berreur M., Couillaud S., Pradal G., Vallette F., Colombeix C., et al. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3. J. Bone Miner. Res. 19 (2004) 1850-1861
14. Brounais B., Chipoy C., Mori K., Charrier C., Battaglia S., Pilet P., et al. Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of Midostaurin in vivo. Clin. Cancer Res. 14 (2008) 5400-5409
15. Bellido T., O'Brien C.A., Roberson P.K., and Manolagas S.C. Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J. Biol. Chem. 273 (1998) 21137-21144
16. de Hooge A.S., van de Loo F.A., Bennink M.B., de Jong D.S., Arntz O.J., Lubberts E., et al. Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. Am. J. Pathol. 160 (2002) 1733-1743
17. Liu F., Aubin J.E., and Malaval L. Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF. Bone 31 (2002) 212-219
18. Thiéry J.-P.P.B., Gongora R., Gongora G., and Mazabraud A. Un modèle experimental d'ostéosarcome chez le rat. II L'ostéosarcome greffable du rat. Sem. Hôp. Paris 58 (1982) 1686-1689
19. Zhang K., Barragan-Adjemian C., Ye L., Kotha S., Dallas M., Lu Y., et al. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol. Cell. Biol. 26 (2006) 4539-4552
20. Demaison C., Parsley K., Brouns G., Scherr M., Battmer K., Kinnon C., et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of immunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum. Gene Ther. 13 (2002) 803-813
21. Genetos D.C., Kephart C.J., Zhang Y., Yellowley C.E., and Donahue H.J. Oscillating fluid flow activation of gap junction hemichannels induces ATP release from MLO-Y4 osteocytes. J. Cell. Physiol. 212 (2007) 207-214
22. Lacreusette A BI, Nguyen JM, Pandolfino MC, Dréno B, Jacques Y, Godard A BF. Defective activations of STAT3 Ser727 and PKC isoforms lead to Oncostatin M resistance in metastatic melanoma cells. J Pathol in press.
23. Hughes D.E., Salter D.M., and Simpson R. CD44 expression in human bone: a novel marker of osteocytic differentiation. J. Bone Miner. Res. 9 (1994) 39-44
24. Toyosawa S., Shintani S., Fujiwara T., Ooshima T., Sato A., Ijuhin N., et al. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J. Bone Miner. Res. 16 (2001) 2017-2026
25. Rios H.F., Ye L., Dusevich V., Eick D., Bonewald L.F., and Feng J.Q. DMP1 is essential for osteocyte formation and function. J. Musculoskelet. Neuronal Interact. 5 (2005) 325-327
26. Ruchon A.F., Tenenhouse H.S., Marcinkiewicz M., Siegfried G., Aubin J.E., DesGroseillers L., et al. Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers. J. Bone Miner. Res. 15 (2000) 1440-1450
27. Tanaka-Kamioka K., Kamioka H., Ris H., and Lim S.S. Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J. Bone Miner. Res. 13 (1998) 1555-1568
28. Bonewald L.F., and Johnson M.L. Osteocytes, mechanosensing and Wnt signaling. Bone 42 (2008) 606-615
29. Grant S.L., Douglas A.M., Goss G.A., and Begley C.G. Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells. Growth Factors 19 (2001) 153-162
30. Friedrich M., Hoss N., Stogbauer F., Senner V., Paulus W., Ringelstein E.B., et al. Complete inhibition of in vivo glioma growth by oncostatin M. J. Neurochem. 76 (2001) 1589-1592
31. Zhang X.G., Gu J.J., Lu Z.Y., Yasukawa K., Yancopoulos G.D., Turner K., et al. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J. Exp. Med. 179 (1994) 1337-1342
32. Miles S.A., Martinez-Maza O., Rezai A., Magpantay L., Kishimoto T., Nakamura S., et al. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 255 (1992) 1432-1434
33. Ihn H., and Tamaki K. Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J. Immunol. 165 (2000) 2149-2155
34. Malaval L., Liu F., Vernallis A.B., and Aubin J.E. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors. J. Cell. Physiol. 204 (2005) 585-593
35. Thompson D.L., Sabbagh Y., Tenenhouse H.S., Roche P.C., Drezner M.K., Salisbury J.L., et al. Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts. J. Bone Miner. Res. 17 (2002) 311-320
36. Franz-Odendaal T.A., Hall B.K., and Witten P.E. Buried alive: how osteoblasts become osteocytes. Dev. Dyn. 235 (2006) 176-190
37. Malik N., Haugen H.S., Modrell B., Shoyab M., and Clegg C.H. Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol. Cell. Biol. 15 (1995) 2349-2358